Article

Daily Medication Pearl: Zioptan (Tafluprost Ophthalmic Solution) for Glaucoma, Ocular Hypertension

Tafluprost acid, a prostaglandin analog, is a selective FP prostanoid receptor agonist that is believed to reduce intraocular pressure by increasing uveoscleral outflow.

Medication Pearl of the Day: Zioptan (Tafluprost Ophthalmic Solution)

Indication: Zioptan is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Insight:

  • Dosing: One drop in the affected eye(s) once daily in the evening.
  • Dosage form: Ophthalmic solution containing tafluprost 0.015 mg/mL.
  • Adverse events (AEs): Most common ocular AE is conjunctival hyperemia.
  • Mechanism of action:Tafluprost acid, a prostaglandin analog, is a selective FP prostanoid receptor agonist that is believed to reduce intraocular pressure by increasing uveoscleral outflow. The exact mechanism of action is unknown at this time.
  • Manufacturer: AKORN

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com